Competitive Acquisition Program Includes Long-Acting Anti-Psychotics
Earlier this week, the Centers for Medicare and Medicaid Services (CMS) issued an interim final rule for the Competitive Acquisition Program (CAP) under Medicare Part B that includes long-acting anti-psychotic medications. The National Council with your help fought hard for this result, reflecting our strong commitment to expanding the availability of new medical technologies offered by community-based mental health providers and improving the quality of care for individuals with serious mental illnesses. Click here to read letter.



